Pelican Technology Holdings, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
8
Ending by 2030
Jan 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 27, 2027The maintenance fee for Process for purifying recombinant Plasmodium falciparum circumsporozoite protein (US 9,169,304) comes due Apr 27, 2027. Unpaid by Oct 27, 2027, it lapses early.
- 1 fee due Jul 26, 2027The maintenance fee for Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein (US 9,243,253) comes due Jul 26, 2027. Unpaid by Jan 26, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 23, 2026
- Oct 4 US 8,017,355 Mannitol induced promoter systems in bacterial host cells · term ended
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,618,799 | Bacterial leader sequences for increased expression In force · USPTO record | In force | USPTO record | |
| US 7,833,752 | Bacterial leader sequences for increased expression In force · USPTO record | In force | USPTO record | |
| US 7,985,564 | Expression systems with sec-system secretion In force · USPTO record | In force | USPTO record | |
| US 10,689,640 | Method for Rapidly Screening Microbial Hosts to Identify Certain Strains with Improved Yield And/Or Quality in the Expression of Heterologous Proteins In force · Medium confidence | In force | Medium confidence | |
| US 9,394,571 | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins In force · USPTO record | In force | USPTO record | |
| US 9,580,719 | Method for Rapidly Screening Microbial Hosts to Identify Certain Strains with Improved Yield and/or Quality in the Expression of Heterologous Proteins In force · Low confidence | In force | Low confidence | |
| US 8,906,636 | High level expression of recombinant toxin proteins In force · USPTO record | In force | USPTO record | |
| US 9,708,616 | Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein In force · USPTO record | In force | USPTO record | |
| US 8,455,218 | Methods for G-CSF production in a Pseudomonas host cell In force · USPTO record | In force | USPTO record | |
| US 8,530,171 | High level expression of recombinant toxin proteins In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 17: 4 lapsed for an unpaid fee · 7 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending